Literature DB >> 12048170

Daily infusion of melatonin entrains circadian activity rhythms in the diurnal rodent Arvicanthis ansorgei.

Helge A Slotten1, Sturla Krekling, Bruno Sicard, Paul Pévet.   

Abstract

The effect of exogenous melatonin (MEL) on the circadian system in nocturnal species has been extensively studied, but little is known about its chronobiotic effect in diurnal mammals. The present study investigated the effect of exogenous MEL on the circadian locomotor activity rhythm in the diurnal rodent Arvicanthis ansorgei. Male animals (n=34) were fitted with a subcutaneous catheter for daily infusion of MEL (1 h; 100 microg) and their running wheel activity was recorded. The results showed that administration of MEL to animals free-running in DD entrained their activity rhythm by phase advances at circadian time (CT) 10.62, and by phase delays at CT -0.40 (CT 0, activity onset). The range of entrainment was 17 and 11.5 min for advance and delay stimuli, respectively. Interestingly, in the nocturnal rat and the A. ansorgei, entrainment of the activity rhythm to exogenous MEL by phase advances occurs at exactly the same phase of the circadian cycle. In both nocturnal and diurnal species, the sensitivity window for exogenous MEL is located near the activity/rest transition points. It is concluded that the functional properties of entrainment to exogenous MEL are similar to those of other nonphotic stimuli. Furthermore, A. ansorgei might be an interesting animal model for studies on the chronobiotic effects of exogenous MEL in diurnal mammals including humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048170     DOI: 10.1016/s0166-4328(01)00411-9

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  8 in total

1.  Circadian clocks in rat skin and dermal fibroblasts: differential effects of aging, temperature and melatonin.

Authors:  Cristina Sandu; Taole Liu; André Malan; Etienne Challet; Paul Pévet; Marie-Paule Felder-Schmittbuhl
Journal:  Cell Mol Life Sci       Date:  2015-01-07       Impact factor: 9.261

2.  Light and melatonin inhibit in vivo serotonergic phase advances without altering serotonergic-induced decrease of per expression in the hamster suprachiasmatic nucleus.

Authors:  Ivette Caldelas; Etienne Challet; Michel Saboureau; Paul Pevet
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Melatonin.

Authors:  Paul Pévet
Journal:  Dialogues Clin Neurosci       Date:  2002-03       Impact factor: 5.986

4.  Melatonin in animal models.

Authors:  Paul Pévet
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

Review 5.  Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives.

Authors:  Sylvie Tordjman; Imen Najjar; Eric Bellissant; George M Anderson; Marianne Barburoth; David Cohen; Nemat Jaafari; Olivier Schischmanoff; Rémi Fagard; Enas Lagdas; Solenn Kermarrec; Sophie Ribardiere; Michel Botbol; Claire Fougerou; Guillaume Bronsard; Julie Vernay-Leconte
Journal:  Int J Mol Sci       Date:  2013-10-14       Impact factor: 5.923

6.  Clock Genes and Altered Sleep-Wake Rhythms: Their Role in the Development of Psychiatric Disorders.

Authors:  Annaëlle Charrier; Bertrand Olliac; Pierre Roubertoux; Sylvie Tordjman
Journal:  Int J Mol Sci       Date:  2017-04-29       Impact factor: 5.923

7.  Modeling the effects of cell cycle M-phase transcriptional inhibition on circadian oscillation.

Authors:  Bin Kang; Yuan-Yuan Li; Xiao Chang; Lei Liu; Yi-Xue Li
Journal:  PLoS Comput Biol       Date:  2008-03-28       Impact factor: 4.475

8.  Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.

Authors:  Amandine Descamps; Colette Rousset; Mark J Millan; Mark Millan; Michael Spedding; Philippe Delagrange; Raymond Cespuglio
Journal:  Psychopharmacology (Berl)       Date:  2009-04-16       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.